UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
European journal of clinical microbiology & infectious diseases, ISSN 0934-9723, 02/2019, Volume 38, Issue 2, pp. 265 - 275
Left-sided infective endocarditis | Streptococcus agalactiae | Staphylococcus aureus | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Health care | Prostheses | Echocardiography | Complications | Mortality | Septic shock | Males | Ultrasonic imaging | Streptococcus | Surgery | Endocarditis | Renal failure | Comparative studies | Skin | Conditioning | Comparative analysis | Heart diseases | Index Medicus
Journal Article
BMC infectious diseases, ISSN 1471-2334, 01/2010, Volume 10, Issue 1, pp. 17 - 17
Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Multivariate Analysis | Endocarditis, Bacterial - etiology | Hospital Mortality | Endocarditis, Bacterial - mortality | Humans | Middle Aged | Risk Factors | Logistic Models | Male | Endocarditis, Bacterial - complications | Young Adult | Spain - epidemiology | Adolescent | Adult | Female | Aged | Cohort Studies | Prognosis | Research | Drug therapy | Risk factors | Endocarditis | Distribution | Studies | Confidence intervals | Heart failure | Variables | Prostheses | Mortality | Standard deviation | Multivariate analysis | Index Medicus
Journal Article
BMC infectious diseases, ISSN 1471-2334, 02/2020, Volume 20, Issue 1, pp. 160 - 160
Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Endocarditis, Bacterial - drug therapy | Staphylococcal Infections - drug therapy | Prognosis | Staphylococcus aureus - isolation & purification | Humans | Middle Aged | Risk Factors | Endocarditis, Bacterial - diagnosis | Male | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Diagnostic Tests, Routine | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Staphylococcal Infections - diagnosis | Endocarditis, Bacterial - epidemiology | Staphylococcal Infections - epidemiology | Endocarditis, Bacterial - microbiology | Adult | Female | Aged | Anti-Bacterial Agents - pharmacology | Staphylococcal Infections - microbiology | Staphylococcus aureus - drug effects | Cohort Studies | Prostheses | Nosocomial infection | Hemodialysis | Heart surgery | Infections | Drug resistance | Methicillin | Variables | Fungal diseases | Antibiotic resistance | Chronic obstructive pulmonary disease | Heart failure | Congenital diseases | Life expectancy | Comorbidity | Mortality | Staphylococcus infections | Hospitalization | Patients | Hospitals | Antibiotics | Medical prognosis | Endocarditis | Sepsis | Clinical medicine | Index Medicus | Methicillin resistance | Vancomycin | Staphylococcus aureus
Journal Article
Revista española de enfermedades digestivas, ISSN 1130-0108, 12/2016, Volume 108, Issue 12, pp. 838 - 840
HIV | Visceral leishmaniasis | Colonic involvement | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Colonic Diseases - complications | Leishmaniasis, Visceral - therapy | Colonic Diseases - therapy | Humans | Middle Aged | HIV Infections - complications | Leishmaniasis, Visceral - complications | Male | Leishmaniasis, Visceral - parasitology | Amphotericin B - therapeutic use | Antiprotozoal Agents - therapeutic use | Colonic Diseases - parasitology | Index Medicus | Pathology | Radiology, Nuclear Medicine & Medical Imaging | Surgery | Geriatrics & Gerontology | Pharmacology & Pharmacy | Infectious Diseases | Oncology
Journal Article
Mayo Clinic proceedings, ISSN 0025-6196, 2014, Volume 89, Issue 10, pp. 1397 - 1405
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Echocardiography, Transesophageal | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Hospital Mortality - trends | Propensity Score | Endocarditis - diagnosis | Time Factors | Spain - epidemiology | Endocarditis - mortality | Adult | Female | Aged | Cardiac Surgical Procedures - methods | Retrospective Studies | Endocarditis - surgery | Complications and side effects | Hospital patients | Care and treatment | Prognosis | Patient outcomes | Infective endocarditis | Research | Risk factors | Health aspects | Surgery | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
Mycopathologia (1975), ISSN 0301-486X, 8/2017, Volume 182, Issue 7, pp. 767 - 770
Life Sciences | Medical Microbiology | Microbial Ecology | Microbiology | HIV | Disseminated histoplasmosis | Reactive hemophagocytic syndrome | Plant Sciences | Eukaryotic Microbiology | Life Sciences & Biomedicine | Mycology | Science & Technology | Lymphohistiocytosis, Hemophagocytic - etiology | Liver - pathology | Lymphohistiocytosis, Hemophagocytic - pathology | Biopsy | Histoplasmosis - pathology | Humans | HIV Infections - complications | Histocytochemistry | Histoplasmosis - diagnosis | Microbiological Techniques | HIV patients | Histoplasmosis | Cross infection | Nosocomial infections | HIV (Viruses) | Hemophagocytic syndrome | Yeasts | Liver | Human immunodeficiency virus--HIV | Inflammation | Diagnosis | Macrophages | Index Medicus
Journal Article
7.
Full Text
NEOTROPICAL XENARTHRANS: a data set of occurrence of xenarthran species in the Neotropics
Ecology (Durham), ISSN 0012-9658, 2019, Volume 100, Issue 7, pp. e02663 - n/a
habitat loss | neotropical region | pilosa | biodiversity hotspot | forest fragmentation | neotropical mammals | cingulata | xenarthra | Environmental Sciences & Ecology | Ecology | Life Sciences & Biomedicine | Science & Technology | Carnivores | Hunting | Pressure effects | Climate effects | Ecosystems | Habitat changes | New records | Environmental changes | Pressure | Fragmentation | Datasets | Climate change | Invasive species | Nutrient loss | Threatened species | Insects | Cascades | Data sets | Insect control | Nutrient cycles | Index Medicus
Journal Article
International journal of cardiology, ISSN 0167-5273, 05/2019, Volume 282, pp. 24 - 30
Heart failure | Mortality | Embolism | Bacteremia | Endocarditis | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prospective Studies | Survival Rate - trends | Endocarditis, Bacterial - mortality | Humans | Middle Aged | Male | Cardiac Surgical Procedures - mortality | Hospital Mortality - trends | Endocarditis, Bacterial - surgery | Endocarditis - mortality | Female | Aged | Cardiac Surgical Procedures - methods | Endocarditis - surgery | Infective endocarditis | Patient outcomes | Cardiac patients | Index Medicus
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 11/2014, Volume 69, Issue 11, pp. 3119 - 3126
nosocomial pneumonia | combination treatment | antimicrobial resistance | A. baumannii | healthcare-associated infections | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Prospective Studies | Humans | Middle Aged | Acinetobacter Infections - drug therapy | Sepsis - epidemiology | Male | Sepsis - drug therapy | Acinetobacter Infections - epidemiology | Acinetobacter baumannii - isolation & purification | Female | Aged | Acinetobacter baumannii - drug effects | Anti-Bacterial Agents - administration & dosage | Drug Resistance, Multiple, Bacterial - drug effects | Multidrug resistant organisms | Sepsis | Bacterial infections | Gram-negative bacteria | Antibiotics | Drug therapy | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 11/2018, Volume 321, Issue 1, pp. 69 - 79
KIDNEY-DISEASE | MORTALITY | GFR DECLINE | END-POINT | SAXAGLIPTIN | HEART-FAILURE | SITAGLIPTIN | DEATH | OUTCOMES | CKD | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Kidney Failure, Chronic - mortality | Cardiovascular Diseases - etiology | Double-Blind Method | Cardiovascular Diseases - prevention & control | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Risk Factors | Linagliptin - adverse effects | Proportional Hazards Models | Male | Linagliptin - therapeutic use | Glycated Hemoglobin A | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Hypoglycemia - chemically induced | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Kidney Failure, Chronic - etiology | Type 2 diabetes | Usage | Clinical trials | Research | Risk factors | Complications and side effects | Analysis | Placebos | Linagliptin | Dosage and administration | Kidney diseases | Cardiovascular diseases | Drug therapy | Myocardial infarction | End-stage renal disease | Adjudication | Risk | Effects | Incidence | Vascular diseases | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Peptidase | Epidermal growth factor receptors | Diabetes mellitus | Pancreatitis | Health risks | Hypoglycemia | Insulin | Patients | Placebo effect | Prescription drugs | Renal failure | Infarction | Adults | Diabetes | Index Medicus | Abridged Index Medicus | Online First | Original Investigation
Journal Article